))
When a young Eva Kollisch arrives as a refugee in New York in 1940, she finds a community among socialists who share her values and idealism. She soon discovers ‘the cause’ isn’t as idyllic as it seems. Little does she know this is the beginning of a lifelong commitment to activism and her determination to create radical change in ways that include belonging, love and one's full self. In addition to Eva Kollisch’s memoirs Girl in Movement (2000) and The Ground Under My Feet (2014), LBI’s collections include an oral history interview with Eva conducted in 2014 and the papers of Eva’s mother, poet Margarete Kolllisch, which document Eva’s childhood experience on the Kindertransport. Learn more at www.lbi.org/kollisch . Exile is a production of the Leo Baeck Institute , New York | Berlin and Antica Productions . It’s narrated by Mandy Patinkin. Executive Producers include Katrina Onstad, Stuart Coxe, and Bernie Blum. Senior Producer is Debbie Pacheco. Associate Producers are Hailey Choi and Emily Morantz. Research and translation by Isabella Kempf. Sound design and audio mix by Philip Wilson, with help from Cameron McIver. Theme music by Oliver Wickham. Voice acting by Natalia Bushnik. Special thanks to the Kollisch family for the use of Eva’s two memoirs, “Girl in Movement” and “The Ground Under My Feet”, the Sophia Smith Collection at Smith College and their “Voices of Feminism Oral History Project”, and Soundtrack New York.…
By Jason L. Crowell, MD Jerome H. Grossman MD Graduate Fellow, Harvard Kennedy School Neurologist, Beth Israel Deaconess Medical Center; Steve Pearson, Founder and President, ICER, Lecturer, Department of Population Medicine, Harvard Medical School
…
continue reading
1
How doctors can be a part of the solution
16:20
16:20
Toista Myöhemmin
Toista Myöhemmin
Listat
Tykkää
Tykätty
16:20
What can physicians do in their hospitals and communities to advocate for fair drug prices? What questions should we ask our patients to assess for financial toxicity? In the final episode of the season, we discuss the steps doctors can be taking now to help solve the drug pricing problem.Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
1
What else makes a drug “valuable”?
20:14
20:14
Toista Myöhemmin
Toista Myöhemmin
Listat
Tykkää
Tykätty
20:14
If we only look at the benefits that a drug provides to those patients who take it, we may underestimate its value by ignoring the benefits it provides to the broader healthcare system. In episode 7, we reveal some of the other reasons that can make a drug more valuable than first meets the eye.Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
If a “fair” price rewards the benefit a drug provides, how do we quantify those benefits—both to the patient and, more broadly, to society? Cost-effectiveness analysis is the tool we can use to quantify a drug’s benefit in a way that can be compared across treatments.Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
1
Who sets a drug’s price, and how do we know it’s fair?
22:22
22:22
Toista Myöhemmin
Toista Myöhemmin
Listat
Tykkää
Tykätty
22:22
In episode 5, we review the variety of approaches one might take to settle on what the “fair” price of a drug should be. The most logical solution to this problem is to price the value—set a drug’s price commensurate with the clinical benefits it provides.Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
1
What’s in it for me? Incentives for making new drugs
27:24
27:24
Toista Myöhemmin
Toista Myöhemmin
Listat
Tykkää
Tykätty
27:24
What motivates a drug manufacturer to create a drug in the first place? How do firms stretch the limits of these incentives? In episode 4, we discuss how the “ecosystem” of drug development in the US has led to truly remarkable innovation but also runaway drug prices.Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
1
From Pharma to the Medicine Cabinet: Who Manages the Drugs?
25:23
25:23
Toista Myöhemmin
Toista Myöhemmin
Listat
Tykkää
Tykätty
25:23
Drugmakers, pharmacies, wholesale distributors, physicians, pharmacy benefit managers—the world of prescription drugs can seem extraordinarily complex. In episode 3, we disentangle this spider’s web and answer the question: who decides how much our patients pay at the pharmacy?Kirjoittanut instituteforclinicalandeconomicreview
…
continue reading
Whenever we choose to spend on one thing instead of another, we pay an opportunity cost. And, just like in life, healthcare is an either/or decision. Patients face decisions about how to spend their money on healthcare, just like insurance companies and governments must decide how to spend their finite dollars on healthcare.…
…
continue reading
In the first episode of the series, we discuss the problem of skyrocketing drug prices and the harmful effects they have on our patients. Not only must patients decide what their medications are worth to them, but payers introduce barriers that limit patients’ access to care. More broadly, we also review the ways that drug prices affect all of our …
…
continue reading
In a new podcast series from the Institute for Clinical and Economic Review (ICER), neurologist Dr. Jason Crowell sits down with ICER’s President Dr. Steve Pearson to pry open the black box of US drug pricing and to wrestle with each of the financial and ethical tensions that undergird our current medical infrastructure. A must-listen for physician…
…
continue reading
